Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Screening Among Veterans and Civilians Enrolled in Veterans Health Administration Insurance Programs
Military Medicine · 24.06.2026
DOI: 10.1093/milmed/usag286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Military Medicine, online erschienen am 24.06.2026. Verfasst von Michael Fuchs und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Virginia VA Health Care System, Richmond, VA 23249, United States. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott.
Abstract (Originalsprache)
Introduction
Stool-based testing is used for non-invasive colorectal cancer screening. The multi-target stool DNA (mt-sDNA) test has higher completion rates than other stool-based tests; however, data are scarce on mt-sDNA test adherence among Veterans Health Administration (VHA) insurance plan enrollees in the United States. Materials and Methods We retrospectively assessed adults aged 45 to 75 years prescribed mt-sDNA testing through a VHA insurance plan, including veterans receiving VHA-authorized care and civilians covered by the Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA). Study data were obtained from the Abbott database (August 2022-January 2026). The primary outcome was test completion (adherence) within 365 days of kit shipment. Kaplan–Meier and log-rank analyses were used to evaluate time to adherence, and logistic regression was used to evaluate factors associated with mt-sDNA test adherence.
Results
Of 8,613 enrollees prescribed mt-sDNA testing, 72.4% (n = 6,234) were adherent; median time to adherence was 16 days. Metropolitan residence was associated with lower adherence (reference: small town; adjusted odds ratio [OR], 0.78; 95% confidence interval [CI], 0.65-0.92; P = .004). Factors associated with higher adherence included median annual household income ≥$125k (reference: <$50k; OR, 1.49; CI, 1.04-2.12; P = .029), test prescription by an obstetrician/gynecologist (reference: nurse practitioner/physician assistant; OR, 1.45; CI, 1.10-1.92; P = .009), and opting in to email and text notifications (reference: no digital notification; OR, 2.02; CI, 1.65-2.46; P < .001). Time to adherence differed significantly by outreach type and prior mt-sDNA return history (both log-rank P < .0001).
Conclusions
Adherence to mt-sDNA testing among VHA enrollees was higher than stool-based test adherence rates previously reported among United States veterans or the general population. These findings support broader integration of mt-sDNA testing within VHA colorectal cancer screening programs to help improve screening participation. Future studies could assess follow-up colonoscopy adherence in an effort to optimize colonoscopy utilization.
Autor:innen und Institutionen
- Central Virginia VA Health Care System, Richmond, VA 23249, United States.
- Virginia Commonwealth University, Richmond, VA 23298, United States.
- Abbott, Madison, WI 53719, United States.
- Stanford University, Stanford, CA 94305, United States.
Förderung
- Abbott
Zitieren
APA
Fuchs, M., Gohil, S., Karlitz, J. J., Omar, M., Gilles, H., Pan, J. Y., & Greene, M. (2026). Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Screening Among Veterans and Civilians Enrolled in Veterans Health Administration Insurance Programs. Military Medicine. https://doi.org/10.1093/milmed/usag286
Vancouver
Fuchs M, Gohil S, Karlitz JJ, Omar M, Gilles H, Pan JY, et al. Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Screening Among Veterans and Civilians Enrolled in Veterans Health Administration Insurance Programs. Military Medicine. 2026. doi:10.1093/milmed/usag286
BibTeX
@article{Fuchs2026,
author = {Fuchs, Michael and Gohil, Shrey and Karlitz, Jordan J and Omar, Mohamed and Gilles, Hochong and Pan, Jennifer Yi-Jiun and Greene, Mallik},
title = {Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Screening Among Veterans and Civilians Enrolled in Veterans Health Administration Insurance Programs},
journal = {Military Medicine},
year = {2026},
doi = {10.1093/milmed/usag286}
}
EUVIMED